Aprogen Biologics Inc.
KSC: 003060.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jeong-Chool Kim
- Employees
- 377
- Headquarters
- Seongnam-si, South Korea
- IPO year
- 2000
- Market cap
- ₩45.9B
- Website
- https://www.aprogen.com
Loading 003060…
Loading profile data…Frequently asked questions about 003060
What does Aprogen Biologics Inc. (003060.KS) do?
Aprogen Biologics, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical and Bio business divisions. The Pharmaceutical business division provides synthetic pharmaceuticals such as circulatory system drugs, central nervous system drugs, digestive system drugs, and antibiotics. The Bio busines...
Where does 003060.KS trade?
Aprogen Biologics Inc. (003060.KS) trades on the Korea Exchange.
What sector is 003060.KS in?
Aprogen Biologics Inc. (003060.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aprogen Biologics Inc.?
Jeong-Chool Kim is the chief executive officer of Aprogen Biologics Inc. (003060.KS).
Where is Aprogen Biologics Inc. headquartered?
Aprogen Biologics Inc. is headquartered in South Korea.
Does 003060.KS pay a dividend?
Aprogen Biologics Inc. (003060.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 003060.KS go public?
Aprogen Biologics Inc. (003060.KS) completed its initial public offering in 2000.